Court Revives Zoll Product Safety Suit Following Earlier Premption Ruling
The Eleventh Circuit Court of Appeals reversed a lower court's decision that US FDA regulations pre-empted a product liability suit against Zoll Medical. The suit was filed by the son of a woman who allegedly died after her Zoll LifeVest external defibrillator malfunctioned.
You may also be interested in...
Zoll cited for QS and MDR violations; FDA instructs maker of drug-of-abuse kits to hire a consultant to audit the firm’s manufacturing and quality assurance systems; Ambco Electronics failed to fully investigate and document device failures. Eight quality-related warning letters were listed by FDA from Sept. 12 through Oct. 14.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.
Pear Therapeutics’ Somryst insomnia treatment tool has become the first FDA-cleared product that was reviewed through the agency’s Software Precertification Pilot Program.